Pauls Matthew bought PTHS
October 2, 2025 · Form 4 insider transaction
Pauls Matthew bought 2,123 shares of Pelthos Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 71 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,123
Price
$0.00
Total value
N/A
InsiderPauls Matthew
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 2, 2025
Filing dateDecember 12, 2025
Shares owned after10,616
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
As previously reported on a Form 4 filed July 7, 2025, on July 2, 2025, the Reporting Person was granted 25,478 restricted stock units ("RSUs"), with the initial one third (1/3) of such shares vesting on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two (2) years.